Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OR1J2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DUS4L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM201A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PSMG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCBTB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIMM23B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TTC37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUMO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARVA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCRN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on